Claradele Pharmaceuticals Inc.

Winterville, NC

UEI
CC1MBJJNJ7E9
CAGE
8PDK2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Black American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
522 Stillwater Dr, Winterville, NC 28590, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of a small-molecule immunomodulator for the treatment of melanoma R41CA261311 National Cancer Institute (NIH) $796,484

Quick answers

Is Claradele Pharmaceuticals Inc. registered in SAM.gov?

Yes. Claradele Pharmaceuticals Inc.'s SAM.gov registration is active through February 5, 2027.

What is Claradele Pharmaceuticals Inc.'s most recent federal award?

Claradele Pharmaceuticals Inc.'s most recent federal grant award is Development of a small-molecule immunomodulator for the treatment of melanoma (R41CA261311), from National Cancer Institute (NIH), on July 1, 2022.

On GovTribe

See Claradele Pharmaceuticals Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login